Publications by authors named "Marco Pieraccioli"

Claim this Profile
N
Novel HSPA8-NR4A2 rearrangement in extraskeletal myxoid chondrosarcoma: a sarcoma mimicker of neuroendocrine neoplasia.
Sabina Barresi, Roberto Passa, Silvia Vallese, Evelina Miele, Sara Patrizi, Marco Pieraccioli

Virchows Arch· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient splicing inhibition causes persistent DNA damage and chemotherapy vulnerability in triple-negative breast cancer.
Cinzia Caggiano, Valerio Petrera, Miriana Ferri, Marco Pieraccioli, Eleonora Cesari

Cell Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.
Veronica Ruta, Chiara Naro, Marco Pieraccioli, Adriana Leccese, Livia Archibugi

Cell Rep Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC up-regulation confers vulnerability to dual inhibition of CDK12 and CDK13 in high-risk Group 3 medulloblastoma.
Consuelo Pitolli, Alberto Marini, Marika Guerra, Marco Pieraccioli, Veronica Marabitti

J Exp Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1.
Valentina Panzeri, Marco Pieraccioli, Eleonora Cesari, Pierre de la Grange, Claudio Sette

Nucleic Acids Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Eleonora Cesari, Alessandra Ciucci, Marco Pieraccioli, Cinzia Caggiano, Camilla Nero

J Exp Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis.
Giulia Falconi, Elisa Galossi, Emiliano Fabiani, Marco Pieraccioli, Serena Travaglini

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer.
Marco Pieraccioli, Cinzia Caggiano, Luca Mignini, Chuwei Zhong, Gabriele Babini

Nat Struct Mol Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The androgen receptor couples promoter recruitment of RNA processing factors to regulation of alternative polyadenylation at the 3' end of transcripts.
Cinzia Caggiano, Marco Pieraccioli, Consuelo Pitolli, Gabriele Babini, Dinghai Zheng

Nucleic Acids Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITD AML.
Serena Travaglini, Tiziana Ottone, Daniela Francesca Angelini, Valentina Fiori, Sabrina Dominici, Marco Pieraccioli

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
Lidia Chellini, Marco Pieraccioli, Claudio Sette, Maria Paola Paronetto

J Exp Clin Cancer Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis.
Eleonora Cesari, Maria Loiarro, Chiara Naro, Marco Pieraccioli, Donatella Farini

Cell Death Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation.
Sara Nicolai, Marco Pieraccioli, Artem Smirnov, Consuelo Pitolli, Lucia Anemona

Mol Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF281 is recruited on DNA breaks to facilitate DNA repair by non-homologous end joining.
Sara Nicolai, Robert Mahen, Giuseppe Raschellà, Alberto Marini, Marco Pieraccioli

Oncogene· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.
Pamela Bielli, Vittoria Pagliarini, Marco Pieraccioli, Cinzia Caggiano, Claudio Sette

Cells· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer.
Cinzia Caggiano, Marco Pieraccioli, Valentina Panzeri, Claudio Sette, Pamela Bielli

Nucleic Acids Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
Pamela Bielli, Valentina Panzeri, Rossano Lattanzio, Simona Mutascio, Marco Pieraccioli

Clin Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Marco Pieraccioli, Sara Nicolai, Consuelo Pitolli, Massimiliano Agostini, Alexey Antonov

Proc Natl Acad Sci U S A· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity, genotoxicity and gene expression changes elicited by exposure of human hepatic cells to Ginkgo biloba leaf extract.
Maria Giuseppa Grollino, Giuseppe Raschellà, Eugenia Cordelli, Paola Villani, Marco Pieraccioli

Food Chem Toxicol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.
Marco Pieraccioli, Francesca Imbastari, Alexey Antonov, Gerry Melino, Giuseppe Raschellà

Cell Cycle· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion.
Giovanna Ferrari-Amorotti, Valentina Fragliasso, Roza Esteki, Zelia Prudente, Angela Rachele Soliera, Marco Pieraccioli

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis